About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,239 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,239 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3581-3600 of 4,239 trials

Enrolling by invitationCombining HD-tDCS and iTBS in Treating Negative Symptoms of SchizophreniaDysfunction of the dorsolateral prefrontal cortex (DLPFC) is central to the persistence of negative symptoms in schizophrenia.NCT07680959·Taipei Active not recruitingA Food Effect Study of LY03020 in Healthy SubjectsThis is a randomized, open-label, single-dose, two-period, crossover study to assess the food effect on pharmacokinetics (PK) and safety of LY03020 in healthy subjects.NCT07292233·Beijing UnknownThe Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic SyndromeAlmost all of antipsychotics can induce metabolic syndrome,Genetic factors play a key role in the development of metabolic syndrome,TCF7L2 and SLC30A8 are strongestly correlated…NCT02093858·Changsha, Hunan RecruitingEffects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With SchizophreniaSchizophrenia is a severe and chronic mental disorder that profoundly impacts patients' psychological, social, and occupational functions.NCT07557368·Shanghai

Related Searches

Data from ClinicalTrials.govTerms

Active not recruitingGetting Out of the House: Using Behavioral Activation to Increase Community ParticipationThe goal of this study is to evaluate the effectiveness of an behavioral activation intervention to increase meaningful activity and community participation for people with…NCT06336616·Philadelphia, Pennsylvania

CompletedCognitive and Balance Dual Task Training for People With SchizophreniaAfter developing and pilot testing the training program, including the CogBals software, a 3-arm, single-blinded, randomized controlled trial is used to recruit 84 participants…NCT05341804·Kaohsiung City

CompletedRandomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-PositiveOut of 300 million persons in the United States, about one-half of one percent, or 1.5 million, have a diagnosis of schizophrenia.NCT01927276·Catonsville, Maryland

TerminatedScreening of Niemann-Pick Disease, Type C in a Psychiatric PopulationNiemann-Pick disease, Type C is a rare genetic disorder characterized by a failing in intracellular cholesterol transport, inducing an accumulation of sphingolipids in the brain.NCT02841358·La Tronche

TerminatedTreating Refractory Schizophrenia With rTMSSymptomatic treatment of the negative symptoms in schizophrenia (such as social withdrawal, affective flattening, poor motivation, and apathy) with medications and psychotherapy…NCT02242578·Austin, Texas

UnknownOptimization of Acute Treatment in First Episode SchizophreniaThe study is a multicenter, double-blind, randomized, parallel-group study with first episode schizophrenic patients.NCT00157378·Munich

Active not recruitingIVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2A randomised phase II double-blinded placebo-controlled trial designed to explore the utility of immunotherapy for patients with acute psychosis associated with anti-neuronal…NCT03194815·Cambridge and 9 others

CompletedThe Efficacy of REHACOP Program in SchizophreniaThis study examined the efficacy of an integrative cognitive remediation program (REHACOP) to improve cognition, social cognition, clinical symptoms and functional outcome in…NCT02796417·Bilbao, Biskai

CompletedBexarotene Augmentation of Antipsychotic Treatment for Chronic SchizophreniaBackground: Bexarotene (Targretin) is a synthetic retinoid mainly used for treatment of patients suffer from oncological or dermatological diseases.NCT00535574·Beersheba, Be'er Sheva and 2 others

UnknownFamilies Coping With Mental Illness ProgramThe current study aims to develop and evaluate a practical, short-term support and education program for relatives of individuals with schizophrenia.NCT00435721·Belmont, Massachusetts and 1 other

UnknownVisual Information Processing in Schizophrenia Patients With Visual HallucinationsOccurrence of visual hallucinations (VHs) in schizophrenia depend in part on disorders in the processing of late visual information (Top-Down).NCT03188133

CompletedMedication Adherence in Schizophrenia: Development of a CBT-Based InterventionThis is a randomized pilot study of an intervention based on principles of Cognitive Behavioral Therapy (CBT).NCT00980252·Chicago, Illinois

RecruitingEnhanced Coordinated Specialty Care for Early PsychosisThe goal of this clinical trial is to compare engagement in treatment in coordinated specialty care (CSC) to five extra care elements (CSC 2.0) in first-episode psychosis.NCT06071858·Belmont, Massachusetts and 4 others

TerminatedtDCS & Auditory Hallucinations in SchizophreniaThe aim of this study is to evaluate tDCS effects on schizophrenia symptoms, particularly on auditory verbal hallucinations. tDCS applied with cathodal (inhibitory) electrode over…NCT02227563·Jerusalem, Israel

CompletedNiacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in SchizophreniaIncreasing evidence suggests modulating effects of cannabinoids on time of onset, severity, and outcome of schizophrenia.NCT00376233·Jena, Thuringia

TerminatedA Study of MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionA ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and AggressionNCT03044249·Phoenix, Arizona and 19 others

PreviousPage 180 of 212Next